Loading...
RISING PHARMA HOLDINGS, INC. — Clarithromycin Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #10 buyer for Clarithromycin · $613.6K import value · 16 shipments · UNITED STATES · DGFT Verified
RISING PHARMA HOLDINGS, INC. is the #10 importer of Clarithromycin from India with $613.6K in import value and 16 verified shipments. RISING PHARMA HOLDINGS, INC. holds a 0.3% market share in Clarithromycin imports based in UNITED STATES. The company sources from 1 verified supplier across 8 formulations shipped to 1 country. Overall, RISING PHARMA HOLDINGS, INC. imports 18 pharmaceutical products worth $87.0M across 11 therapeutic categories.
Verified from 16 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AUROBINDO PHARMA LIMITED | $613.6K | 16 | 100.0% |
RISING PHARMA HOLDINGS, INC. sources Clarithromycin from 1 verified Indian supplier based on 16 customs records. The primary supplier is AUROBINDO PHARMA LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $750.0K | 15 | $50.0K |
| 13 | ABACUS PHARMA LTD | UGANDA | $650.0K | 13 | $50.0K |
| 16 | RISING PHARMA HOLDINGS, INC. ★ | UNITED STATES | $650.0K | 13 | $50.0K |
| 9 | AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $550.0K | 11 | $50.0K |
| 4 | HEKO PHARMACY LTD | TANZANIA | $500.0K | 10 | $50.0K |
RISING PHARMA HOLDINGS, INC. ranks #10 among 811 Clarithromycin importers from India. Average shipment value of $50.0K compared to the market average of $26.1K. The closest competitors by value are AUROLOGISTICS LLC, (AUROBINDO PHARM and ABACUS PHARMA LTD.
Destination countries from 16 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $613.6K | 16 | 100.0% |
RISING PHARMA HOLDINGS, INC. imports Clarithromycin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $613.6K.
| Formulation | Value | Shipments |
|---|---|---|
| CLARITHROMYCIN TABLETS 500 MG (28560X60S)NOS | $150.0K | 3 |
| CLARITHROMYCIN TABLETS 500 MG (27168X60S) | $150.0K | 3 |
| CLARITHROMYCIN TABLETS 500 MG (7920X60'S) | $108.4K | 3 |
| CLARITHROMYCIN TABLETS 500 MG (24624X60'S) | $50.0K | 1 |
| CLARITHROMYCIN TABLETS 500 MG (Clarithromycin Tablets USP 500 mg) (19920X60'S) | $50.0K | 1 |
| CLARITHROMYCIN TABLETS 250MG (5280X60'S)NOS | $37.6K | 3 |
| CLARITHROMYCIN TABLETS 250MG (CLARITHROM | $37.2K | 1 |
| CLARITHROMYCIN TABLETS 500 MG (2256X60'S) | $30.3K | 1 |
RISING PHARMA HOLDINGS, INC. imports from India.
What RISING PHARMA HOLDINGS, INC. and other importers must comply with to import Clarithromycin from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $21.2M worth of Clarithromycin through 3,576 shipments from 334 suppliers to 144 countries, serving 811 buyers globally. RISING PHARMA HOLDINGS, INC. imports $613.6K of this total, accounting for 0.3% of India's Clarithromycin exports with 16 shipments from UNITED STATES. This is verified from 16 customs shipment records covering 8 distinct formulations.
RISING PHARMA HOLDINGS, INC.'s average Clarithromycin order value is $38.4K per consignment, based on 16 shipments totaling $613.6K. RISING PHARMA HOLDINGS, INC. is based in UNITED STATES and ranks #10 among all Clarithromycin importers from India by value. The company sources from 1 verified supplier in India.
RISING PHARMA HOLDINGS, INC. sources Clarithromycin from 1 verified Indian supplier: AUROBINDO PHARMA LIMITED ($613.6K, 100.0%). This is based on 16 customs records.
RISING PHARMA HOLDINGS, INC. ranks #10 among 811 Clarithromycin importers from India with a 0.3% market share. The top 3 importers are YUSEN LOGISTICS BENELUX BELGIUM ($9.2M), BROWN AND BURK UK LIMITED ($1.6M), YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN ($1.3M). RISING PHARMA HOLDINGS, INC. processed 16 shipments from UNITED STATES.
RISING PHARMA HOLDINGS, INC. imports 18 products worth $87.0M. Beyond Clarithromycin, top products include Gabapentin, Furosemide, Ondansetron, Pioglitazone, Escitalopram. View the complete RISING PHARMA HOLDINGS, INC. profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Clarithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for RISING PHARMA HOLDINGS, INC.'s Clarithromycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
RISING PHARMA HOLDINGS, INC.
Full Company Profile →
18 products · $87.0M total trade · 11 categories
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 144+ countries, 811+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for RISING PHARMA HOLDINGS, INC..
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clarithromycin. For current order-level data, contact TransData Nexus.